Job/Unit: Z13150
/KAP1
Date: 21-05-13 16:49:20
Pages: 14
L. H. Finger, F. G. Schröder, J. Sundermeyer
ARTICLE
3.86 mmol). Single crystals could be obtained but did not lead to a
publishable solution so far.
3-methylimidazolium bisulfate (356 mg, 1.71 mmol) in water (20 mL).
The suspension was stirred for three days and then filtered. The solu-
tion was evaporated to dryness and the residue recrystallised from a
hot mixture of acetone and water. Single crystals suitable for XRD
were obtained by layering a concentrated solution in acetonitrile with
diethyl ether. Yield: 220 mg (0.87 mmol, 52%).
C2Cs2N8 (401.90 g·mol–1) C 6.09 (calcd. 5.89), N 27.92 (27.88); 13C
NMR (75.5 MHz, D2O): δ = 154.6 (s, CN4) ppm. IR (ATR): 733 (m),
1006 (s), 1035 (m), 1111 (w), 1120 (w), 1130 (m), 1169 (m), 1290 (s),
1314 (s) cm–1; TGA (10 K·min–1): 392 (decomp.) °C; DSC
(10 K·min–1): 402 (exoth.) °C.
C8H12N10 (248.25 g·mol–1) C 38.48 (calcd. 38.71), H 4.80 (4.87), N
55.60 (56.42)%; 1H NMR (300.1 MHz, [D6]DMSO): δ = 1.40 (t, 3 H,
3J(H,H) = 7.2 Hz, CH2CH3), 3.85 (s, 3 H, Me), 4.19 (q, 3JH,H = 7.2 Hz,
2 H, CH2CH3), 7.70 (s, 1 H, HIm), 7.78 (s, 1 H, HIm), 9.15 (s, 1 H,
HIm), 16.19 (br. s, 1 H, HBT) ppm; 13C NMR (75.5 MHz, [D6]DMSO):
δ = 15.0 (s, CH2CH3), 35.7 (s, CH3), 44.1 (s, CH2CH3), 121.9 (s, CIm),
123.5 (s, CIm), 136.3 (s, CIm), 149.4 (s, CN4) ppm. IR (ATR): 412 (w),
483 (s), 627 (s), 650 (s), 703 (m), 758 (s), 866 (m), 890 (m), 999 (m),
1017 (m), 1029 (m), 1092 (m), 1161 (s), 1281 (m), 1341 (s), 1465 (w),
1560 (w), 1574 (w), 1617 (w), 2300–2700 (w, br), 3112 (w), 3141 (w)
cm–1; TGA (10 K·min–1): 266 (decomp.) °C; DSC (10 K·min–1): 147
(endoth.), 282 (exoth.) °C; M. P. (2 K·min–1): 145.5 °C.
Barium 5,5’-bistetrazolate pentahydrate (7h): Barium hydroxide
octahydrate (3.88 g, 12.3 mmol) and 5,5Ј-bistetrazole (1.70 g,
12.3 mmol) were dissolved in boiling water (100 mL). The solution
was filtered hot and slowly cooled to room temperature. The product
crystallised in 79% yield (3.55 g, 9.77 mmol), single crystals suitable
for XRD analysis could be obtained.
Pentahydrate: C2H10BaN8O5 (363.49 g·mol–1) C 6.61 (calcd. 6.61), H
2.20 (2.77); N 31.00 (30.83)%; 13C NMR (75.5 MHz, D2O): δ = 155.4
(s, CN4) ppm. IR (ATR): 400–850 (s, br), 1021 (s), 1048 (m), 1121
(w), 1151 (m), 1181 (s), 1308 (s), 1327 (s), 1650 (m), 2700–3600 (s,
br) cm–1. The comparatively high deviation of the hydrogen value may
indicate a partial mixture of e.g. the penta- and tetrahydrate. This is
not confirmed by the nitrogen value, though. Drying the Substance in
air at room temperature yielded the dihydrate after four days.
Bis(1-ethyl-3-methylimidazolium) 5,5’-bistetrazolate (11): A solu-
tion of 5,5’-bistetrazole (349 mg, 2.53 mmol) in dry methanol (10 mL)
was slowly added to a solution of 1-Ethyl-3-methylimidazolium
methyl carbonate (938 mg, 5.04 mmol) in dry methanol (5 mL). Slow
gas evolution was observed and the mixture was heated to 50 °C for
sixteen hours before the solvent was removed in vacuo. The residue
was recrystallised by layering a concentrated solution in dry acetoni-
trile with dry diethyl ether. Large crystals suitable for XRD formed
within hours, crystallisation was complete after a few days. After a
second recrystallisation from dry acetonitrile at –30 °C 560 mg
(1.56 mmol, 62%) of the pure product were obtained.
Dihydrate: C2H4BaN8O2 (309.45 g·mol–1) C 7.70 (calcd. 7.76), H 1.26
(1.30), N 35.94 (36.21)%. IR (ATR): 542 (s, br), 571 (s, sh), 675 (m,
br), 725 (m), 819 (w, br), 1019 (m), 1047 (w), 1085 (w), 1143 (w),
1186 (w), 1218 (w), 1310 (m), 1339 (m), 3057 (w, br) 3523 (w, br)
cm–1.
Drying the product at 120 °C in fine vacuum for four hours yielded
the water-free salt.
C14H22N12 (358.41 g·mol–1) C 47.10 (calcd. 46.92), H 6.21 (6.19), N
46.91 (46.90)%; 1H NMR (300.1 MHz, [D6]DMSO): δ = 1.37 (t, 3 H,
C2BaN8 (273.42 g·mol–1) C 8.79 (calcd. 8.79), N 41.54 (40.98)%. IR
(ATR): 728 (m), 1021 (s), 1057 (m), 1085 (w), 1143 (s), 1191 (m),
1312 (m), 1340 (s) cm–1.
3
3JH,H = 7.1 Hz, CH2CH3), 3.89 (s, 3 H, Me), 4.25 (q, JH,H = 7.1 Hz,
2 H, CH2CH3), 7.76 (s, 1 H, HIm), 7.85 (s, 1 H, HIm), 9.67 (s, 1 H,
HIm) ppm; 13C NMR (75.5 MHz, [D6]DMSO): δ = 15.2 (s, CH2CH3),
35.5 (s, CH3), 44.0 (s, CH2CH3), 121.9 (s, CIm), 123.5 (s, CIm), 136.8
(s, CIm), 156.0 (s, CN4) ppm. IR (ATR): 621 (m), 651 (s), 732 (s), 739
(s), 800 (m), 850 (w), 894 (m), 1006 (w), 1027 (m), 1094 (w), 1156
(s), 1293 (m), 1315 (m), 1428 (w), 1453 (w), 1561 (m), 1659 (w),
2978 (w), 3053 (m), 3136 (w) cm–1 TGA (10 K·min–1): 250 (decomp.)
°C; DSC (10 K·min–1): 94.5 (endoth.), 298 (exoth.) °C; M. P.
(2 K·min–1): 92.5 °C.
Ammonium 5,5’-bistetrazolate (9): Diammonium 5,5’-bistetrazolate
(554 mg, 3.22 mmol) and 5,5’-bistetrazole (445 mg, 3.22 mmol) were
dissolved in water (25 mL), the solution heated to reflux and then
evaporated to dryness. The residue was recrystallised from a minimum
amount of hot water (ca. 5 mL) so that an aqueous solution at 115 °C
in a closed flask was saturated. The solution was then slowly cooled to
room temperature yielding needles of diammonium 5,5’-bistetrazolate
(201 mg, 1.17 mmol, 36% of the starting material. C2H8N10
(172.15 g·mol–1) C 13.86 (calcd. 13.95), H 4.55 (4.68), N 80.98
(81.36)%). The supernatant solution was transferred to a second flask
and slowly cooled to 4 °C whereupon the desired product crystallised
in 60% yield (302 mg, 1.95 mmol). Single crystals suitable for XRD
were obtained.
Supporting Information (see footnote on the first page of this article):
Table with bond lengths, bond angles and torsion angles in the bistetra-
zolate anions of compounds, 1h to 4h, 6, 7h and 8 to 11; TGA and
DSC Curve of (EMIM)2BT (11).
C2H5N9 (155.12 g·mol–1) C 15.65 (calcd. 15.49); H 2.92 (3.25), N
80.64 (81.27)%; 13C NMR (75.5 MHz, D2O): 149.4 (s, CN4) ppm. IR
(ATR): 426 (m), 476 (s), 687 (m), 851 (s, br), 1009 (s), 1070 (m),
1105 (m), 1224 (w), 1282 (m), 1335 (w), 1377(s), 1409 (m), 1528
(w), 2100–3300 (m, br); TGA (10 K·min–1): 282 (decomp.) °C; DSC
(10 K·min–1): 289 (exoth.) °C. The deviation of the nitrogen value
in the elemental analysis may be attributed to the product not being
completely pure. The tendency of equimolecular solutions of diammo-
nium 5,5’-bistetrazole and the free acid to yield the diammonium salt
upon crystallisation makes it not possible to purify the product by
recrystallisation.
Acknowledgments
Financial support by the Studienstiftung des deutschen Volkes and the
Fond der Chemischen Industrie is gratefully acknowledged. We thank
Jens Eußner (M. Sc.) for his introduction into and continued help with
TGA/ DSC measurements. We are very thankful to Dr. Klaus Harms
for fruitful discussions and valuable advice regarding XRD single crys-
tal structure determination.
References
1-Ethyl-3-methylimidazolium 5,5’-bistetrazolate (10): Barium 5,5’-
[1] E. Oliveri-Mandalà, T. Passalacqua, Gazz. Chim. Ital. 1913, 43(2)
bistetrazolate (467 mg, 1.71 mmol) was added to a solution of 1-ethyl-
, 465–475.
12
© 0000 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Z. Anorg. Allg. Chem. 0000, 0–0